Skip to main content

Table 3 Cox regression model for progression (vs. fibrosis < 5%)

From: Automated computed tomography quantification of fibrosis predicts prognosis in combined pulmonary fibrosis and emphysema in a real-world setting: a single-centre, retrospective study

 

Fibrosis 5–10%

Fibrosis ≥ 10%

HR (95% CI)

p value

HR (95% CI)

p value

Fibrosis proportion only

7.42

(3.31, 16.65)

 < 0.001

5.61

(2.47, 12.74)

 < 0.001

Adjusted for age and sex

7.42

(3.28, 16.79)

 < 0.001

5.76

(2.49, 13.35)

 < 0.001

Adjusted for age, sex, pack-years smoking, and CCI

7.58

(3.34, 17.24)

 < 0.001

6.24

(2.65, 14.71)

 < 0.001

Adjusted for age, sex, pack-years smoking, CCI,

lung cancer, and CTD

7.49

(3.27, 17.16)

 < 0.001

6.17

(2.60, 14.63)

 < 0.001

Adjusted for age, sex, pack-years smoking, CCI,

lung cancer, CTD, and IPF

6.85

(2.95, 15.89)

 < 0.001

5.78

(2.42, 13.85)

 < 0.001

  1. Hazard ratios are shown (with 95% confidence intervals in parentheses)
  2. CCI Charlson Comorbidity Index, CTD connective tissue disease, IPF idiopathic pulmonary fibrosis, CI confidence interval